跳至主要内容
临床试验/CTRI/2019/05/019267
CTRI/2019/05/019267Other未知

ED90 of Prophylactic Oxytocin Infusion During Cesarean Delivery in Laboring Preeclamptics receiving Magnesium Sulfate Therapy versus Normotensives: An Up-Down Sequential Allocation Dose-Response Study - None

CMS and GTBH0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
Other
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • All laboring parturients >18 years age who have received oxytocin for labor induction and/or augmentation, whether preeclamptics who are receiving magnesium sulfate therapy (posted for cesarean section under spinal block/general anaesthesia) or normotensives without magnesium sulfate therapy( posted for cesarean section under spinal block) will be enrolled.

排除标准

  • Exclusion criteria will include patient refusa, history of PPH or more than one previous uterine surgery as well as bleeding disorders, and presence of abnormal placentation, uterine fibroid. Those with any contraindication to spinal block such as hemodynamic instability, infection at site of injection, coagulopathy (thrombocytopenia with platelet count <100,000/mm3) etc. will also be excluded

研究者

发起方
CMS and GTBH

相似试验